Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · CMS publication 2026-06-30 View official record

Covered recipient · General Payments record

DANA MEREDITH CHASE

Allopathic & Osteopathic Physicians Obstetrics & Gynecology Gynecologic Oncology

NPI
1396888947
CMS profile
290086
Location
LOS ANGELES, CA

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

Saved items

Saved only in this browser. No account or alerts.

Filter and download payment records

General Payments · PY2020 · Entire year

$102,429.83

75 records · 0 disputed

Summary and payment records

  • CMS publication 2026-06-30
Read the payment records

Other CMS categories — not shown on this page

Research Payments

CMS also publishes Research Payments as a separate dataset. This site does not currently mirror it, and no research figure is shown on this page. This provider appears in that dataset.

“If you are a physician who served as a principal investigator on a research study, you may see the payments associated with that research study listed under your name. This does not necessarily mean the payments are attributed to you. The dollar amount of the record corresponds to the total payment; the amounts are not attributed to each individual on the record.”

— Centers for Medicare & Medicaid Services, Open Payments Frequently Asked Questions, FAQ #12224

These records are published by CMS and can be viewed on this provider’s official CMS record. View this provider on CMS Open Payments ↗

“Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.”

— Centers for Medicare & Medicaid Services, Open Payments

A reported payment reflects a financial relationship a company disclosed. It does not indicate wrongdoing or a conflict of interest, and it says nothing about the quality of a provider's care.

These records are submitted to CMS and attested to by the reporting companies. CMS publishes them as reported; this site mirrors them without independent verification.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

How these totals are calculated
  • This total is the sum of the individual General Payments record amounts CMS published for the labeled program year(s); each record amount is used unmodified. The total itself is computed by this site. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Methodology & Data — sourcing, labeling, and limitations.

Provider summaries generated . CMS updates this data on an annual cycle, and corrections or successful disputes made at CMS may not yet appear here. The official CMS record is authoritative for the current state. View the official CMS record ↗

By nature of payment

PY2020 · entire year · sorted by reported total

By paying entity

PY2020 · entire year · sorted by reported total

Paying entityAmountRecords
AstraZeneca Pharmaceuticals LP $63,106.93 35
GlaxoSmithKline, LLC. $13,172.62 12
Baxter Healthcare $8,968.95 13
Clovis Oncology, Inc. $4,705.62 4
Pharmacosmos Therapeutics Inc. $3,678.00 2
Myriad Genetic Laboratories, Inc. $3,143.59 4
Dova Pharmaceuticals $2,500.00 1
Seagen Inc. $1,610.00 1
Merck Sharp & Dohme Corporation $1,500.00 1
BeiGene USA, Inc. $32.84 1
CooperSurgical, Inc. $11.28 1

Payment records · PY2020

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

General Payments · PY2020 · Physicians and non-physician practitioners · CMS publication 2026-06-30

75 matching records · $102,429.83 reported total · 0 disputed

Nature of payment: All payment types

Records imported here (UTC).

Link to these filtered records · CMS source dataset ↗

Download all 75 matching records (CSV)

CSV includes CMS record IDs, source and publication dates, the data edition, and a link to these filters. Formula-like text cells are prefixed with an apostrophe for spreadsheet safety.

Showing records 1–50 of 75.

Paying entityAmountDate Nature of paymentDispute statusPublication flagsPublished Record IDSource
AstraZeneca Pharmaceuticals LP $3,450.0012/17/2020 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/2026736036493 CMS
AstraZeneca Pharmaceuticals LP $1,350.0012/16/2020 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026736221457 CMS
Seagen Inc. $1,610.0012/11/2020 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/2026732452739 CMS
Merck Sharp & Dohme Corporation $1,500.0012/09/2020 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/2026747829591 CMS
AstraZeneca Pharmaceuticals LP $1,350.0011/24/2020 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026735901449 CMS
GlaxoSmithKline, LLC. $1,400.0011/24/2020 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026738509563 CMS
GlaxoSmithKline, LLC. $1,400.0011/19/2020 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026738639387 CMS
Myriad Genetic Laboratories, Inc. $24.1711/12/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026727387565 CMS
AstraZeneca Pharmaceuticals LP $1,350.0011/10/2020 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026736008449 CMS
AstraZeneca Pharmaceuticals LP $5,480.0011/09/2020 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/2026735800631 CMS
AstraZeneca Pharmaceuticals LP $1,350.0011/09/2020 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026736377127 CMS
AstraZeneca Pharmaceuticals LP $1,350.0010/26/2020 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026736262627 CMS
AstraZeneca Pharmaceuticals LP $1,350.0010/25/2020 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026735781449 CMS
AstraZeneca Pharmaceuticals LP $2,750.0010/25/2020 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026736407139 CMS
GlaxoSmithKline, LLC. $1,625.0010/24/2020 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/2026738877687 CMS
Clovis Oncology, Inc. $293.4410/14/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026722235439 CMS
GlaxoSmithKline, LLC. $1,400.0010/08/2020 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026738797651 CMS
AstraZeneca Pharmaceuticals LP $131.9610/06/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026735859043 CMS
AstraZeneca Pharmaceuticals LP $1,712.5010/01/2020 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/2026736161959 CMS
Dova Pharmaceuticals $2,500.0010/01/2020 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/2026752353945 CMS
Pharmacosmos Therapeutics Inc. $528.0009/29/2020 Honoraria No dispute reported Delay: No
Change: UNCHANGED
06/30/2026736868964 CMS
AstraZeneca Pharmaceuticals LP $2,750.0009/15/2020 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026736330347 CMS
AstraZeneca Pharmaceuticals LP $2,740.0009/14/2020 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/2026735843379 CMS
AstraZeneca Pharmaceuticals LP $5,500.0009/08/2020 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026735808607 CMS
GlaxoSmithKline, LLC. $1,400.0009/03/2020 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026738950043 CMS
Pharmacosmos Therapeutics Inc. $3,150.0009/01/2020 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/2026736869111 CMS
AstraZeneca Pharmaceuticals LP $118.4108/27/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026736028819 CMS
AstraZeneca Pharmaceuticals LP $129.8508/27/2020 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026736161121 CMS
AstraZeneca Pharmaceuticals LP $221.3808/27/2020 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026736311129 CMS
BeiGene USA, Inc. $32.8408/15/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026752947701 CMS
Clovis Oncology, Inc. $21.6608/15/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026722235727 CMS
GlaxoSmithKline, LLC. $325.0008/14/2020 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/2026738623573 CMS
AstraZeneca Pharmaceuticals LP $5,500.0008/03/2020 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026736255183 CMS
CooperSurgical, Inc. $11.2807/31/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026744548789 CMS
AstraZeneca Pharmaceuticals LP $719.5007/28/2020 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026735885975 CMS
AstraZeneca Pharmaceuticals LP $77.3207/28/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026736305177 CMS
GlaxoSmithKline, LLC. $1,400.0007/16/2020 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026738510219 CMS
Myriad Genetic Laboratories, Inc. $1,500.0007/15/2020 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/2026727387571 CMS
GlaxoSmithKline, LLC. $297.6206/23/2020 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026738872403 CMS
Myriad Genetic Laboratories, Inc. $119.4206/17/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026727387561 CMS
AstraZeneca Pharmaceuticals LP $12.3406/03/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026736276229 CMS
AstraZeneca Pharmaceuticals LP $600.0006/02/2020 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026736092701 CMS
GlaxoSmithKline, LLC. $1,300.0005/29/2020 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/2026738631859 CMS
GlaxoSmithKline, LLC. $325.0005/29/2020 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/2026738770261 CMS
GlaxoSmithKline, LLC. $1,000.0005/21/2020 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026738902701 CMS
Clovis Oncology, Inc. $4,250.0004/28/2020 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/2026722235363 CMS
Baxter Healthcare $54.0004/23/2020 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026714304567 CMS
Baxter Healthcare $7,920.0004/23/2020 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026714304569 CMS
Myriad Genetic Laboratories, Inc. $1,500.0004/17/2020 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/2026727387567 CMS
AstraZeneca Pharmaceuticals LP $6,850.0003/22/2020 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/2026736019164 CMS

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2019 $287,401.65 290
PY2020 $102,429.83 75
PY2021 $100,131.71 70
PY2022 $181,662.00 124
PY2023 $253,425.55 170
PY2024 $219,218.10 141
PY2025 $144,892.79 99

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-06-30
Program years on this page
2019, 2020, 2021, 2022, 2023, 2024, 2025
Source files and profile matching
Generated from
OP_DTL_GNRL_PGYR2025_P06302026_06032026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.

Cite this record.

Plain
DANA MEREDITH CHASE, NPI 1396888947. IndustryPayments, data edition 2026-07-26T04:22:22Z. https://industrypayments.org/provider/npi-1396888947.
APA 7
IndustryPayments. (2026). DANA MEREDITH CHASE, NPI 1396888947 (Data edition 2026-07-26T04:22:22Z) [Data set]. https://industrypayments.org/provider/npi-1396888947
Bluebook
DANA MEREDITH CHASE, NPI 1396888947, IndustryPayments (data edition 2026-07-26T04:22:22Z), https://industrypayments.org/provider/npi-1396888947.

Source: Centers for Medicare & Medicaid Services, Open Payments.